A Multi-Center, Open-Labeled Study of the Safety, Efficacy, and Pharmacokinetics of Lubiprostone in Pediatric Patients With Constipation.

Trial Profile

A Multi-Center, Open-Labeled Study of the Safety, Efficacy, and Pharmacokinetics of Lubiprostone in Pediatric Patients With Constipation.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Lubiprostone (Primary)
  • Indications Constipation
  • Focus Therapeutic Use
  • Sponsors Sucampo Pharmaceuticals
  • Most Recent Events

    • 10 Oct 2013 Results have been presented at the 2013 North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) Annual Meeting according to a Sucampo Pharmaceuticals media release. Results were also summarised in the media release.
    • 09 Oct 2013 Results were published in the Journal of Pediatric Gastroenterology & Nutrition.
    • 09 Oct 2013 Primary endpoint 'Spontaneous-bowel-movement' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top